Opko Health Stock Forward View - Double Exponential Smoothing
| OPK Stock | USD 1.19 -0.02 -1.65% |
This module analyzes aggregated news and social signals around Opko Health to forecast near-term price direction. It is best used as one input among several, alongside fundamental and technical analysis.
Per the latest calculation, Opko Health posts the 14-period RSI reading of 43, reflecting mild downside bias. This range suggests moderated price movement without extreme directional pressure.Momentum
Sell Extended
Oversold | Overbought |
Quarterly Earnings Growth -0.13 | EPS Estimate Next Quarter -0.08 | EPS Estimate Current Year -0.34 | EPS Estimate Next Year -0.33 | Wall Street Target Price 3.4 |
This section summarizes Opko Health headline activity and related price response context. Options and short interest metrics are combined here to describe sentiment for Opko Health.
Short Interest Activity for Opko Health
Short sellers in Opko Health profit when Opko Health's stock falls below their entry price. Monitoring short interest helps long investors understand the magnitude of selling pressure they face.
200 Day MA 1.3459 | Short Percent 0.072 | Short Ratio 9.75 | Shares Short Prior Month 30.9 M | 50 Day MA 1.2576 |
RSI Momentum View - Opko
The Double Exponential Smoothing forecasted value of Opko Health on the next trading day is expected to be 1.19 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.27.Hype and Price Context: Opko Health
When Opko Health's news sentiment peaks, stock prices often follow with a lag. Similarly, sentiment troughs can mark price bottoms if fundamental business quality remains intact.
Tracking how Opko Health's sentiment evolves after major announcements helps investors assess whether the market's reaction was proportionate or whether an over-correction created a new entry opportunity in Opko Health.
Opko Health Implied Volatility | 1.45 |
The implied volatility skew for Opko Health options - the difference in implied volatility between puts and calls at different strikes - reveals the market's asymmetric fear of downside versus upside moves in Opko Health's stock.
The Double Exponential Smoothing forecasted value of Opko Health on the next trading day is expected to be 1.19 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.27.Opko Health after-hype prediction price | $ 1.19 |
This module presents attention signals alongside forecasting, technical analysis, analyst consensus, and earnings.
Cross-verify projections for Opko Health using Historical Fundamental Analysis of Opko Health. The historical view provides additional context.Rule 16 Reference for the current Opko contract - Pricing Context
Based on Rule 16, the market-implied daily move for 2026-06-18 options is about 0.0906%. This estimate is a volatility reference; at $ 1.19, it implies a move of about $ 0.001078 per day.
Open Interest Distribution for Opko 2026-06-18 Options
Active contract counts for Opko Health are shown through open interest, offering positioning and liquidity context.
Opko Health Additional Predictive Modules
Most predictive techniques to examine Opko price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Opko using various technical indicators. When you analyze Opko charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Opko Health Double Exponential Smoothing Price Forecast For the 12th of March 2026
Given 90 days horizon, the Double Exponential Smoothing forecasted value of Opko Health on the next trading day is expected to be 1.19 with a mean absolute deviation of 0.02 , mean absolute percentage error of 0.0007 , and the sum of the absolute errors of 1.27 .Please note that although there have been many attempts to predict Opko Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Opko Health's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Opko Health Stock Forecast Pattern
| Backtest Opko Health | Opko Health Price Prediction | Research Analysis |
Opko Health Forecasted Value
This next-day forecast for Opko Health uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Opko Health stock data series using in forecasting. Note that when a statistical model is used to represent Opko Health stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.0042 |
| MAD | Mean absolute deviation | 0.0212 |
| MAPE | Mean absolute percentage error | 0.0167 |
| SAE | Sum of the absolute errors | 1.2744 |
The mean reversion framework for Opko Health is built on the premise that markets are not perfectly efficient and that prices periodically overshoot their intrinsic value in both directions.
Opko Health After-Hype Price Density Analysis
Visualizing the full distribution of potential Opko Health outcomes discourages binary thinking about investments. Rather than asking whether Opko Health's price will go up or down, the distribution approach asks: what is the range of outcomes and how probable is each?
Next price density |
| Expected price to next headline |
Opko Health Estimiated After-Hype Price Volatility
The news-based price prediction model for Opko Health is transparent: it measures how Opko Health's has historically reacted to news, not how it will theoretically behave. Opko Health's after-hype downside and upside margins for the prediction period are 0.06 and 3.18, respectively. Investors should use this model as one input among many when evaluating Opko Health ahead of anticipated news.
Current Value
The after-hype framework applied to Opko Health assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Opko Health Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Opko Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Opko Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Opko Health, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.24 | 1.99 | 0.01 | 0.18 | 8 Events | 8 Events | In 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.19 | 1.19 | 0.00 |
|
Opko Health Hype Timeline
On the 11th of March 2026 Opko Health is traded for 1.19. The company has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.18. Opko is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at -0.24%. %. The volatility of related hype on Opko Health is about 259.79%, with the expected price after the next announcement by competition of 1.01. About 49.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.73. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Opko Health recorded a loss per share of 0.3. The company had not issued any dividends in recent years. Considering the 90-day investment horizon the next projected press release will be in 8 days. Cross-verify projections for Opko Health using Historical Fundamental Analysis of Opko Health. The historical view provides additional context.Opko Health Related Hype Analysis
The peer hype analysis for Opko Health identifies which competitors tend to lead the sector in their news reactions. These leading indicators provide early signals about the direction of Opko Health's upcoming performance.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SANA | Sana Biotechnology | 0.1 | 8 per month | 0.00 | -0.06 | 8.49 | -7.71 | 28.66 | |
| CTEV | Claritev | -9.44 | 9 per month | 0.00 | -0.13 | 10.44 | -8.18 | 56.65 | |
| XNCR | Xencor Inc | -0.12 | 9 per month | 0.00 | -0.14 | 5.99 | -6.16 | 25.51 | |
| OCS | Oculis Holding AG | 0.72 | 10 per month | 1.86 | 0.23 | 5.79 | -3.64 | 16.37 | |
| PSNL | Personalis | -0.33 | 9 per month | 0.00 | -0.03 | 8.66 | -9.60 | 27.29 | |
| NKTR | Nektar Therapeutics | 0.56 | 11 per month | 4.22 | 0.08 | 7.00 | -7.17 | 58.13 | |
| TNDM | Tandem Diabetes Care | -0.91 | 9 per month | 2.74 | 0.05 | 5.39 | -4.93 | 39.25 | |
| LFMD | LifeMD Inc | -0.15 | 8 per month | 4.05 | 0.04 | 12.03 | -6.38 | 28.11 | |
| DNTH | Dianthus Therapeutics | 1.88 | 8 per month | 2.39 | 0.23 | 9.85 | -4.89 | 22.93 | |
| PCRX | Pacira BioSciences | 0.03 | 17 per month | 0.00 | -0.02 | 3.44 | -5.80 | 12.30 |
Other Forecasting Options for Opko Health
Price movement is the most fundamental factor that determines whether Opko is a viable investment for any investor. Opko Stock price charts are often noisy, making it difficult to identify meaningful patterns without analytical tools.Opko Health Related Equities
The following equities are related to Opko Health within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Opko Health against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Opko Health Market Strength Events
Assessing the market strength of Opko Health stock provides investors with a clearer picture of how the security reacts to evolving market dynamics. These indicators can be used to identify periods when trading Opko Health is most likely to be profitable.
Opko Health Risk Indicators
The analysis of Opko Health's basic risk metrics provides a foundation for forecasting its future price and managing investment risk. Identifying the magnitude of risk in Opko Health's helps investors choose between accepting or hedging their exposure.
| Mean Deviation | 1.49 | |||
| Standard Deviation | 1.96 | |||
| Variance | 3.86 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Opko Health
Coverage intensity for Opko Health matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Opko Health Short Properties
Short sentiment tied to Opko Health matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 765.5 M | |
| Cash And Short Term Investments | 369.1 M |
More Resources for Opko Stock Analysis
Reviewing Opko Health commonly begins with financial statements and performance trends. Key ratios help frame profitability, efficiency, and growth context for Opko Health Stock. Below are reports that help frame Opko Health Stock in context:Cross-verify projections for Opko Health using Historical Fundamental Analysis of Opko Health. The historical view provides additional context. Learn how to buy and trade Opko Stock using our step-by-step How to Buy Opko Health guide.Analysis related to Opko Health should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Quarterly Earnings Growth -0.13 | Earnings Share -0.30 | Revenue Per Share | Quarterly Revenue Growth -0.19 | Return On Assets |
Understanding Opko Health includes distinguishing between market value and book value, where book value reflects Opko accounting equity. Opko Health's market capitalization is 913.56 M. A P/B ratio of 0.73 suggests Opko Health trades near or below book value. Enterprise value stands at 949.97 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for Opko Health differs from its quoted price, since each reflects a different lens. For Opko Health, key inputs include a P/E ratio of 7.46, a P/B ratio of 0.73, a profit margin of -37.19%, ROE of -17.14%. By contrast, market price reflects the level where buyers and sellers transact.